SPE Capital, an investment firm focused on Africa and the Middle East, has announced the acquisition, by its private equity fund SPE AIF I, of a majority stake in Vital, the leading nutritional supplements producer in Tunisia. Vital constitutes the fund’s 9th investment and the 4th in 2022.
Established in 2000, Vital has grown into the leading dietary supplements and herbal medicine manufacturer in Tunisia, with a portfolio of over 400 high quality branded products, marketed in Tunisia and internationally, and 8 million units manufactured each year.
Over the past few years, the company has grown to 400 employees and established itself as the leader in the nutritional supplements market in Tunisia, on the back of continuous new product development and consistent organic growth.
This investment confirms SPE Capital’s commitment to furthering the healthcare and wellness sectors in North Africa and comes on the heels of investments in sectors including pharmaceuticals manufacturing and fitness.
The investment in Vital includes a primary capital investment to further scale up the company’s product portfolio, boost its sales & marketing and drive its international expansion over the coming years.
SPE Capital was advised by Louati & Associates Law Firm (legal advisor), PwC Tunisia (financial and tax advisor), ERM and IBIS (ESG and Impact advisors), Galenisys and BlueBirds (Commercial and strategic advisors).